News Agency
Men's Weekly

New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia

  • Written by PR Newswire
New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia

NSW and Myeloid entered into a partnership in February 2023 to launch state-of-the-art GMP manufacturing RNA facility

CAMBRIDGE, Mass., Sept. 12, 2023 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage oncology company, has dosed the first patient with MT-302 in a Phase 1 study for advanced or metastatic epithelial tumors....

Read more: New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with...

How Labour Hire Supports Sydney and Gold Coast Businesses

Labour hire has transformed from a simple stopgap measure into one of the most strategically valuable workforce solutions for businesses right across Sydney and the Gold Coast. As various industries grow, adapt to punishing seasonal demand, or suddenly find themselves... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion